Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

by
November 12, 2021
in Latest News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded companies. The news sent shares higher in premarket trading.

The separation will sheer off its household products unit, maker of Band-Aid bandages, Aveeno and Neutrogena skin care products and Listerine, from its riskier, but faster-growing division that makes and sells prescription drugs and medical devices, including its Covid-19 vaccine.

RELATED POSTS

Pro Picks: Watch all of Friday’s big stock calls on CNBC

Rocket Lab targets $50 million launch price for Neutron rocket to challenge SpaceX’s Falcon 9

“Following a comprehensive review, the board and management team believe that the planned separation of the consumer health business is the best way to accelerate our efforts to serve patients, consumers, and healthcare professionals, create opportunities for our talented global team, drive profitable growth, and – most importantly – improve healthcare outcomes for people around the world,” outgoing CEO Alex Gorsky said in a statement.

The company said it hopes to complete the transaction in 18 to 24 months. The pharmaceutical and medical device division, which includes advanced technologies like robotics and AI, would retain the name Johnson & Johnson and have J&J’s incoming CEO Joaquin Duato at its helm.

Duato is taking over the role in January as previously planned. Those segments are expected to generate roughly $77 billion in revenue while the consumer products division is forecast to sell about $15 billion in products this year, the company said.

Its yet-to-be-named consumer products company will also inherit litigation stemming from lawsuits over claims that its Johnson’s Baby Powder causes cancer, allegations the company has vehemently denied.

Shares of J&J were up more than 3% in premarket trading after the announcement.

J&J was already undergoing a major transition with Gorsky’s departure as CEO. He will remain on as executive chairman of the new J&J, the company said.

Additionally, the company said it planned to keep its total dividend “at least at the same level” following the change. J&J currently sports a dividend yield of about 2.6%.

The announcement comes just days after General Electric said it plans to split into three separate companies, spinning out its medical unit from its aviation and energy units.

ShareTweetPin

Related Posts

Pro Picks: Watch all of Friday’s big stock calls on CNBC

by
March 24, 2023
0

Market Movers rounds up the best trade ideas from investors and analysts throughout the day. Jim Cramer talked about Deutsche...

Rocket Lab targets $50 million launch price for Neutron rocket to challenge SpaceX’s Falcon 9

by
March 24, 2023
0

In this article RKLB Follow your favorite stocksCREATE FREE ACCOUNT Rocket Lab Rocket Lab is building a bigger, reusable launch...

Nearly $100 billion in deposits pulled from banks; officials call system ‘sound and resilient’

by
March 24, 2023
0

A First Citizens Bank branch in Dunwoody, Georgia, on Thursday, March 23, 2023. Elijah Nouvelage | Bloomberg | Getty Images...

Charles Schwab Stock Got Hit in the Bank Mess. Be Careful.

by
March 24, 2023
0

Charles Schwab and the Bank Mess: Sizing Up the Firm’s Risks | Barron's As Silicon Valley Bank imploded and shares...

Hotels: Occupancy Rate Down 2.5% Compared to Same Week in 2019

by
March 24, 2023
0

by Calculated Risk on 3/24/2023 03:01:00 PM From CoStar: STR: Weekly US Hotel Occupancy Inches Closer to 70% in Mid-March...

Next Post

Black Knight: Number of Mortgages in Forbearance Declines

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com